Platform for molecular/cellular neurosciences!
NBT facility encompasses 4 complementary services (P3Bio, Neuro-Vir, Connecto-Vir and BioClin). While access to P3Bio is restricted to INT members, Neuro-Vir, Connecto-Vir and BioClin are opened to INT team collaborators as well as external users (service submitted to a fee)(to inquire about services conditions and pricing information please contact : eduardo.gascon-gonzalo at univ-amu.fr or gilbert.baillat at univ-amu.fr)
P3Bio (Molecular BIOlogy, cell BIOlogy and et BIOchemistry facility) is an INT common service. P3Bio aims are :
Neuro-Vir is a vector development and production service especially designed for neuroscientists. Neuro-Vir offers the state of the art technologies and savoir-faire to generate high quality AAVs or lentiviral vectors for in vitro (cell lines, stem cells or primary cultures) or in vivo applications (rodent and non-human primates brain). Production is performed following the highest biosafety standards (from BSL-I to BSL-III laboratory) from the national competent agency (Haut Conseil des Biotechnologies) and from the internal biosafety committee.
More specifically Neuro-Vir provides :
Connecto-Vir offers the use of neurotropic viruses (rabies or herpes) for those scientists interested in exploring the functional neuroanatomy in mammals (rodents and non-human primates). Under the supervision of Dr Patrice Coulon (patrice.coulon at univ-amu.fr) and ensuring the respect of national and international ethical guidelines, Connecto-Vir provides the following services :
This service aims at promoting translational research at INT and helping in the transition from basic research implemented at the institute to preclinical studies in collaboration with the hospital and/or biopharmaceuticals companies (e.g. biomarkers research). BioClin benefits from the support and expertise of the Immunology Laboratory at the University Hospital of Marseille (Director Dr J. Boucraut jose.boucraut at univ-amu.fr). BioClin will provide advice, feedback and support in the elaboration of clinical protocols (e.g. autorizations, ethical rules …). It will also serve as an incubator to promote reciprocal interactions between basic researchers and clinicians (e.g. choice of human samples, cohorts design, selection of the most appropriate biological technique for a particular project …)